Goldenheim PD - Search Results

1

Circadian variations in theophylline concentrations and the treatment of nocturnal asthma.

Martin RJ, Cicutto LC, Ballard RD, Goldenheim PD, Cherniack RM. Martin RJ, et al. Among authors: goldenheim pd. Am Rev Respir Dis. 1989 Feb;139(2):475-8. doi: 10.1164/ajrccm/139.2.475. Am Rev Respir Dis. 1989. PMID: 2913892 Clinical Trial.

2

Treatment of asthma by a controlled-release theophylline tablet formulation: a review of the North American experience with nocturnal dosing.

Goldenheim PD, Conrad EA, Schein LK. Goldenheim PD, et al. Chronobiol Int. 1987;4(3):397-408. doi: 10.3109/07420528709083529. Chronobiol Int. 1987. PMID: 3315269 Review.

3

Chronotherapy of reversible airways disease with once-daily evening doses of a controlled-release theophylline preparation.

Goldenheim PD, Schein LK. Goldenheim PD, et al. Ann N Y Acad Sci. 1991;618:490-503. doi: 10.1111/j.1749-6632.1991.tb27267.x. Ann N Y Acad Sci. 1991. PMID: 2006803

4

Once-daily evening administration of Uniphyl tablets: announcement of first available chronotherapy of nocturnal asthma.

Goldenheim PD. Goldenheim PD. Chronobiol Int. 1989;6(3):199-201. doi: 10.3109/07420528909056919. Chronobiol Int. 1989. PMID: 2805149 No abstract available.

5

The United States experience with oral controlled-release morphine (MS Contin tablets). Parts I and II. Review of nine dose titration studies and clinical pharmacology of 15-mg, 30-mg, 60-mg, and 100-mg tablet strengths in normal subjects.

Kaiko RF, Grandy RP, Oshlack B, Pav J, Horodniak J, Thomas G, Ingber E, Goldenheim PD. Kaiko RF, et al. Among authors: goldenheim pd. Cancer. 1989 Jun 1;63(11 Suppl):2348-54. doi: 10.1002/1097-0142(19890601)63:11<2348::aid-cncr2820631146>3.0.co;2-v. Cancer. 1989. PMID: 2720580

6

A multi-investigator clinical evaluation of oral controlled-release morphine (MS Contin tablets) administered to cancer patients.

Lazarus H, Fitzmartin RD, Goldenheim PD. Lazarus H, et al. Among authors: goldenheim pd. Hosp J. 1990;6(4):1-15. doi: 10.1080/0742-969x.1990.11882680. Hosp J. 1990. PMID: 2088995 Clinical Trial.

7

Incidence and clinical correlates of nocturnal awakening secondary to dyspnea in chronic obstructive airway disease (COAD).

Braun SR, Lee BR, Conrad EA, Scott GC, Goldenheim PD. Braun SR, et al. Among authors: goldenheim pd. Chest. 1990 Mar;97(3 Suppl):80S-81S. Chest. 1990. PMID: 2307014 No abstract available.

8

A bioequivalence study of oral controlled-release morphine using naltrexone blockade.

Kaiko RF, Grandy RP, Reder RF, Goldenheim PD, Sackler RS. Kaiko RF, et al. Among authors: goldenheim pd. J Clin Pharmacol. 1995 May;35(5):499-504. doi: 10.1002/j.1552-4604.1995.tb04094.x. J Clin Pharmacol. 1995. PMID: 7657850 Clinical Trial.

9

Pharmacokinetic-pharmacodynamic relationships of controlled-release oxycodone.

Kaiko RF, Benziger DP, Fitzmartin RD, Burke BE, Reder RF, Goldenheim PD. Kaiko RF, et al. Among authors: goldenheim pd. Clin Pharmacol Ther. 1996 Jan;59(1):52-61. doi: 10.1016/S0009-9236(96)90024-7. Clin Pharmacol Ther. 1996. PMID: 8549034

10

The bioavailability of morphine in controlled-release 30-mg tablets per rectum compared with immediate-release 30-mg rectal suppositories and controlled-release 30-mg oral tablets.

Kaiko RF, Fitzmartin RD, Thomas GB, Goldenheim PD. Kaiko RF, et al. Among authors: goldenheim pd. Pharmacotherapy. 1992;12(2):107-13. Pharmacotherapy. 1992. PMID: 1570227 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

44 results

Search Page